Down-regulated miR-448 relieves spinal cord ischemia/reperfusion injury by up-regulating SIRT1

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Spinal cord ischemia/reperfusion injury (SCII) is a severe condition with limited treatment options.
• MicroRNAs (miRNAs) are key regulators in cellular processes and disease progression.
• The specific roles of miR-448 and SIRT1 in SCII pathogenesis require further elucidation.

Purpose of the Study:

• To investigate the functional role of miR-448 and SIRT1 in spinal cord ischemia/reperfusion injury (SCII).
• To explore the underlying molecular mechanisms connecting miR-448 and SIRT1 in SCII.
• To assess the therapeutic potential of modulating miR-448 for SCII treatment.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and Western blot to measure gene and protein expression.
• Flow cytometry for assessing nerve cell apoptosis.
• In vivo rat model of SCII using abdominal aorta clamping.
• Basso, Beattie, and Bresnahan (BBB) score and motor deficit index for functional evaluation.
• Dual-luciferase reporter assay to confirm direct interaction between miR-448 and SIRT1.

Main Results:

• miR-448 expression was significantly upregulated, while SIRT1 expression was downregulated in SCII tissues and hypoxic nerve cells.
• Hypoxia-induced upregulation of miR-448 led to decreased SIRT1 expression and increased nerve cell apoptosis.
• Downregulation of miR-448 significantly improved hind-limb motor function and neurological recovery in SCII rats by upregulating SIRT1.
• Reduced miR-448 expression inhibited nerve cell apoptosis and enhanced functional recovery in SCII models.

Conclusions:

• miR-448 acts as a detrimental factor in SCII by suppressing SIRT1, thereby promoting nerve cell apoptosis.
• Modulating miR-448 levels presents a potential therapeutic strategy for mitigating SCII.
• Targeting the miR-448/SIRT1 axis offers promising avenues for preventing and treating spinal cord ischemia/reperfusion injury.